Follow the people · Insider
Terrance P. Coyne
Terrance P. Coyne files insider transactions with the SEC as an evp & cfo of Royalty Pharma (RPRX). We hold 12 disclosed purchases and sales filed since 23 June 2020, 1 of them in the last 90 days.
- Files forRPRX
- Disclosed buys and sells12 in all, 1 in the last 90 days
- Last disclosure17 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 June 2020 — 13 August 2026EVP & CFO · Royalty Pharma (RPRX)96 Form 4 lines · source: SEC Form 4
Everything they disclosed
96 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 9,230 shares of Royalty PharmaSEC Form 417 August 2026Class A Ordinary Shares · traded 13 August 2026 · filed 17 August 2026
- ▼ sold on the open market 1,772 shares of Royalty PharmaSEC Form 417 August 2026Class A Ordinary Shares · traded 13 August 2026 · filed 17 August 2026
- was granted 11,002 shares of Royalty PharmaSEC Form 47 August 2026Class A Ordinary Shares · traded 5 August 2026 · filed 7 August 2026
- gave away 18,500 shares of Royalty Pharma (a derivative holding)SEC Form 47 August 2026Class E Ordinary Shares · traded 7 August 2026 · filed 7 August 2026
- ▼ sold on the open market 64,399 shares of Royalty PharmaSEC Form 428 May 2026Class A Ordinary Shares · traded 26 May 2026 · filed 28 May 2026
- was granted 24,263 shares of Royalty PharmaSEC Form 48 May 2026Class A Ordinary Shares · traded 6 May 2026 · filed 8 May 2026
- ▼ sold on the open market 32,916 shares of Royalty PharmaSEC Form 430 April 2026Class A Ordinary Shares · traded 28 April 2026 · filed 30 April 2026
- ▼ sold on the open market 1,875 shares of Royalty PharmaSEC Form 430 April 2026Class A Ordinary Shares · traded 28 April 2026 · filed 30 April 2026
- ▼ sold on the open market 1,875 shares of Royalty PharmaSEC Form 42 April 2026Class A Ordinary Shares · traded 1 April 2026 · filed 2 April 2026
- ▼ sold on the open market 32,916 shares of Royalty PharmaSEC Form 42 April 2026Class A Ordinary Shares · traded 1 April 2026 · filed 2 April 2026
- ▼ sold on the open market 32,916 shares of Royalty PharmaSEC Form 425 March 2026Class A Ordinary Shares · traded 23 March 2026 · filed 25 March 2026
- ▼ sold on the open market 1,875 shares of Royalty PharmaSEC Form 425 March 2026Class A Ordinary Shares · traded 23 March 2026 · filed 25 March 2026
- ▼ sold on the open market 32,916 shares of Royalty PharmaSEC Form 425 March 2026Class A Ordinary Shares · traded 23 March 2026 · filed 25 March 2026
- ▼ sold on the open market 1,875 shares of Royalty PharmaSEC Form 425 March 2026Class A Ordinary Shares · traded 23 March 2026 · filed 25 March 2026
- ▼ sold on the open market 22,487 shares of Royalty PharmaSEC Form 44 March 2026Class A Ordinary Shares · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 10,429 shares of Royalty PharmaSEC Form 44 March 2026Class A Ordinary Shares · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 1,292 shares of Royalty PharmaSEC Form 44 March 2026Class A Ordinary Shares · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 583 shares of Royalty PharmaSEC Form 44 March 2026Class A Ordinary Shares · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 22,487 shares of Royalty PharmaSEC Form 44 March 2026Class A Ordinary Shares · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 10,429 shares of Royalty PharmaSEC Form 44 March 2026Class A Ordinary Shares · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 1,292 shares of Royalty PharmaSEC Form 44 March 2026Class A Ordinary Shares · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 583 shares of Royalty PharmaSEC Form 44 March 2026Class A Ordinary Shares · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 32,916 shares of Royalty PharmaSEC Form 425 February 2026Class A Ordinary Shares · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 1,875 shares of Royalty PharmaSEC Form 425 February 2026Class A Ordinary Shares · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 32,916 shares of Royalty PharmaSEC Form 425 February 2026Class A Ordinary Shares · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 1,875 shares of Royalty PharmaSEC Form 425 February 2026Class A Ordinary Shares · traded 23 February 2026 · filed 25 February 2026
- was granted 26,626 shares of Royalty PharmaSEC Form 413 February 2026Class A Ordinary Shares · traded 11 February 2026 · filed 13 February 2026
- was granted 26,626 shares of Royalty PharmaSEC Form 413 February 2026Class A Ordinary Shares · traded 11 February 2026 · filed 13 February 2026
- ▼ sold on the open market 102,581 shares of Royalty PharmaSEC Form 44 February 2026Class A Ordinary Shares · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 108,759 shares of Royalty PharmaSEC Form 44 February 2026Class A Ordinary Shares · traded 3 February 2026 · filed 4 February 2026
- ▼ sold on the open market 19,076 shares of Royalty PharmaSEC Form 44 February 2026Class A Ordinary Shares · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 5,843 shares of Royalty PharmaSEC Form 44 February 2026Class A Ordinary Shares · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 6,195 shares of Royalty PharmaSEC Form 44 February 2026Class A Ordinary Shares · traded 3 February 2026 · filed 4 February 2026
- ▼ sold on the open market 1,087 shares of Royalty PharmaSEC Form 44 February 2026Class A Ordinary Shares · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 102,581 shares of Royalty PharmaSEC Form 44 February 2026Class A Ordinary Shares · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 108,759 shares of Royalty PharmaSEC Form 44 February 2026Class A Ordinary Shares · traded 3 February 2026 · filed 4 February 2026
- ▼ sold on the open market 19,076 shares of Royalty PharmaSEC Form 44 February 2026Class A Ordinary Shares · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 5,843 shares of Royalty PharmaSEC Form 44 February 2026Class A Ordinary Shares · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 6,195 shares of Royalty PharmaSEC Form 44 February 2026Class A Ordinary Shares · traded 3 February 2026 · filed 4 February 2026
- ▼ sold on the open market 1,087 shares of Royalty PharmaSEC Form 44 February 2026Class A Ordinary Shares · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 65,832 shares of Royalty PharmaSEC Form 423 January 2026Class A Ordinary Shares · traded 20 January 2026 · filed 23 January 2026
- ▼ sold on the open market 3,750 shares of Royalty PharmaSEC Form 423 January 2026Class A Ordinary Shares · traded 20 January 2026 · filed 23 January 2026
- ▼ sold on the open market 65,832 shares of Royalty PharmaSEC Form 423 January 2026Class A Ordinary Shares · traded 20 January 2026 · filed 23 January 2026
- ▼ sold on the open market 3,750 shares of Royalty PharmaSEC Form 423 January 2026Class A Ordinary Shares · traded 20 January 2026 · filed 23 January 2026
- ▼ sold on the open market 65,832 shares of Royalty PharmaSEC Form 46 January 2026Class A Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 3,750 shares of Royalty PharmaSEC Form 46 January 2026Class A Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 65,832 shares of Royalty PharmaSEC Form 46 January 2026Class A Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 3,750 shares of Royalty PharmaSEC Form 46 January 2026Class A Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 65,832 shares of Royalty PharmaSEC Form 417 December 2025Class A Ordinary Shares · traded 15 December 2025 · filed 17 December 2025
- ▼ sold on the open market 3,750 shares of Royalty PharmaSEC Form 417 December 2025Class A Ordinary Shares · traded 15 December 2025 · filed 17 December 2025
- ▼ sold on the open market 65,832 shares of Royalty PharmaSEC Form 43 December 2025Class A Ordinary Shares · traded 1 December 2025 · filed 3 December 2025
- ▼ sold on the open market 3,750 shares of Royalty PharmaSEC Form 43 December 2025Class A Ordinary Shares · traded 1 December 2025 · filed 3 December 2025
- ▼ sold on the open market 55,146 shares of Royalty PharmaSEC Form 426 November 2025Class A Ordinary Shares · traded 24 November 2025 · filed 26 November 2025
- ▼ sold on the open market 10,686 shares of Royalty PharmaSEC Form 426 November 2025Class A Ordinary Shares · traded 24 November 2025 · filed 26 November 2025
- ▼ sold on the open market 3,126 shares of Royalty PharmaSEC Form 426 November 2025Class A Ordinary Shares · traded 24 November 2025 · filed 26 November 2025
- ▼ sold on the open market 624 shares of Royalty PharmaSEC Form 426 November 2025Class A Ordinary Shares · traded 24 November 2025 · filed 26 November 2025
- ▼ sold on the open market 65,844 shares of Royalty PharmaSEC Form 419 November 2025Class A Ordinary Shares · traded 17 November 2025 · filed 19 November 2025
- ▼ sold on the open market 3,750 shares of Royalty PharmaSEC Form 419 November 2025Class A Ordinary Shares · traded 17 November 2025 · filed 19 November 2025
- was granted 6,168 shares of Royalty PharmaSEC Form 47 November 2025Class A Ordinary Shares · traded 5 November 2025 · filed 7 November 2025
- gave away 1,000 shares of Royalty Pharma (a derivative holding)SEC Form 48 August 2025LP interests in RPI US Partners 2019, LP · traded 8 August 2025 · filed 8 August 2025
- was granted 3,696 shares of Royalty PharmaSEC Form 48 August 2025Class A Ordinary Shares · traded 6 August 2025 · filed 8 August 2025
- was granted 1,807,277 shares of Royalty Pharma (a derivative holding)SEC Form 420 May 2025Class E Ordinary Shares · traded 16 May 2025 · filed 20 May 2025
- was granted 48,646 shares of Royalty PharmaSEC Form 49 May 2025Class A Ordinary Shares · traded 8 May 2025 · filed 9 May 2025
- gave away 2,000 shares of Royalty Pharma (a derivative holding)SEC Form 412 August 2024ICAI Interests · traded 12 August 2024 · filed 12 August 2024
- ▼ sold on the open market 37,500 shares of Royalty PharmaSEC Form 411 August 2023Class A Ordinary Shares · traded 9 August 2023 · filed 11 August 2023
- ▼ sold on the open market 37,500 shares of Royalty PharmaSEC Form 411 August 2023Class A Ordinary Shares · traded 10 August 2023 · filed 11 August 2023
- gave away 1,650 shares of Royalty Pharma (a derivative holding)SEC Form 48 August 2023ICAI Interests · traded 8 August 2023 · filed 8 August 2023
- ▼ sold on the open market 37,500 shares of Royalty PharmaSEC Form 414 July 2023Class A Ordinary Shares · traded 12 July 2023 · filed 14 July 2023
- ▼ sold on the open market 37,500 shares of Royalty PharmaSEC Form 414 July 2023Class A Ordinary Shares · traded 13 July 2023 · filed 14 July 2023
- ▼ sold on the open market 24,500 shares of Royalty PharmaSEC Form 410 November 2022Class A Ordinary Shares · traded 8 November 2022 · filed 10 November 2022
- ▼ sold on the open market 5,500 shares of Royalty PharmaSEC Form 44 November 2022Class A Ordinary Shares · traded 2 November 2022 · filed 4 November 2022
- ▼ sold on the open market 30,000 shares of Royalty PharmaSEC Form 43 August 2022Class A Ordinary Shares · traded 1 August 2022 · filed 3 August 2022
- converted 1,000,000 shares of Royalty PharmaSEC Form 411 May 2021Class A Ordinary Shares · traded 7 May 2021 · filed 11 May 2021
- converted 100,000 shares of Royalty Pharma (a derivative holding)SEC Form 411 May 2021LP interests in RPI US Partners 2019, LP · traded 7 May 2021 · filed 11 May 2021
- ▼ sold on the open market 29,820 shares of Royalty PharmaSEC Form 45 March 2021Class A Ordinary Shares · traded 3 March 2021 · filed 5 March 2021
- ▼ sold on the open market 57,723 shares of Royalty PharmaSEC Form 45 March 2021Class A Ordinary Shares · traded 3 March 2021 · filed 5 March 2021
- ▼ sold on the open market 11,001 shares of Royalty PharmaSEC Form 45 March 2021Class A Ordinary Shares · traded 3 March 2021 · filed 5 March 2021
- ▼ sold on the open market 1,456 shares of Royalty PharmaSEC Form 45 March 2021Class A Ordinary Shares · traded 3 March 2021 · filed 5 March 2021
- ▼ sold on the open market 94,978 shares of Royalty PharmaSEC Form 44 March 2021Class A Ordinary Shares · traded 2 March 2021 · filed 4 March 2021
- ▼ sold on the open market 5,022 shares of Royalty PharmaSEC Form 44 March 2021Class A Ordinary Shares · traded 2 March 2021 · filed 4 March 2021
- was granted 2,605 shares of Royalty Pharma (a derivative holding)SEC Form 45 January 2021LP interests in RPI International Holdings 2019, LP · traded 15 June 2020 · filed 5 January 2021
- converted 2,417 shares of Royalty Pharma (a derivative holding)SEC Form 45 January 2021LP interests in RPI International Holdings 2019, LP · traded 18 June 2020 · filed 5 January 2021
- converted 24,170 shares of Royalty PharmaSEC Form 45 January 2021Class A Ordinary Shares · traded 18 June 2020 · filed 5 January 2021
- converted 99,770 shares of Royalty PharmaSEC Form 45 January 2021Class A Ordinary Shares · traded 31 December 2020 · filed 5 January 2021
- converted 300,230 shares of Royalty PharmaSEC Form 45 January 2021Class A Ordinary Shares · traded 31 December 2020 · filed 5 January 2021
- converted 9,977 shares of Royalty Pharma (a derivative holding)SEC Form 45 January 2021LP interests in RPI US Partners 2019, LP · traded 31 December 2020 · filed 5 January 2021
- converted 30,023 shares of Royalty Pharma (a derivative holding)SEC Form 45 January 2021LP interests in RPI US Partners 2019, LP · traded 31 December 2020 · filed 5 January 2021
- was granted 10,755 shares of Royalty Pharma (a derivative holding)SEC Form 423 June 2020LP interests in RPI US Partners 2019, LP · traded 15 June 2020 · filed 23 June 2020
- was granted 406,491 shares of Royalty Pharma (a derivative holding)SEC Form 423 June 2020LP interests in RPI US Partners 2019, LP · traded 15 June 2020 · filed 23 June 2020
- was granted 2,508 shares of Royalty Pharma (a derivative holding)SEC Form 423 June 2020LP interests in RPI International Holdings 2019, LP · traded 15 June 2020 · filed 23 June 2020
- was granted 305,000 shares of Royalty Pharma (a derivative holding)SEC Form 423 June 2020ICAI Interests · traded 15 June 2020 · filed 23 June 2020
- was granted 48,000 shares of Royalty Pharma (a derivative holding)SEC Form 423 June 2020ICAI Interests · traded 15 June 2020 · filed 23 June 2020
- converted 2,327 shares of Royalty Pharma (a derivative holding)SEC Form 423 June 2020LP interests in RPI International Holdings 2019, LP · traded 18 June 2020 · filed 23 June 2020
- ▲ bought on the open market 1,500 shares of Royalty PharmaSEC Form 423 June 2020Class A Ordinary Shares · traded 18 June 2020 · filed 23 June 2020
- ▲ bought on the open market 1,450 shares of Royalty PharmaSEC Form 423 June 2020Class A Ordinary Shares · traded 18 June 2020 · filed 23 June 2020
- converted 23,270 shares of Royalty PharmaSEC Form 423 June 2020Class A Ordinary Shares · traded 18 June 2020 · filed 23 June 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.